Form 4 for ROIV Roivant Sciences Ltd.
Accepted 2022-12-09 00:00:00 ET · period of report 2022-12-08 · accession 0001140361-22-045162 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-12-09 | 2022-12-08+ | ROIV | Venker Eric | Pres, COO | S - Sale | $7.03 | -145.1K | 888.7K | -14% | -$1.02M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2022-12-08 | S | D | 11,729 | $7.00 | 1,022,118 | D | — | — | |
| 2 | Common | Common Shares | 2022-12-09 | S | D | 133,376 | $7.03 | 888,742 | D | — | — |